 Home > Medical News > Latest Medical News > Pioneer Pharmaceuticals completes the first patient administration in the treatment of COVID-19 in the U.S. Phase III clinical trial with procrulamide

Pioneer Pharmaceuticals completes the first patient administration in the treatment of COVID-19 in the U.S. Phase III clinical trial with procrulamide

 Last Update: 2021-05-23
 Source: Internet
 Author: User

Tags

microvascular disease treatment

ind clinical trial

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On the 25th, the pioneering pharmaceutical industry announced that the Phase III clinical trial of Prokalamide for the treatment of male patients with mild and moderate new coronary disease approved by the US FDA has completed the enrollment and administration of the first subject in a clinical center in the US.

The study of procluamide in the treatment of male patients with mild and moderate COVID-19 is a randomized, double-blind, placebo-controlled, global multi-center phase III pivotal clinical trial, which aims to explore the treatment of procluamide in male patients with mild and moderate COVID-19 Effectiveness and safety.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.